(Q53126117)

English

An IgG3 switch variant of rituximab mediates enhanced complement-dependent cytotoxicity against tumour cells with low CD20 expression levels.

scientific article published on 7 January 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23294176

An IgG3 switch variant of rituximab mediates enhanced complement-dependent cytotoxicity against tumour cells with low CD20 expression levels. (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23294176

0 references

1 reference

based on heuristic

inferred from title

Christian Kellner

3

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23294176

Gestur Vidarsson

6

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23294176

author name string

Thies Rösner

1

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23294176

Stefanie Derer

2

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23294176

Michael Dechant

4

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23294176

Stefan Lohse

5

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23294176

Matthias Peipp

7

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23294176

Thomas Valerius

8

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23294176

language of work or name

0 references

publication date

7 January 2013

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23294176

British Journal of Haematology

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23294176

161

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23294176

2

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23294176

282-286

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23294176

Human monoclonal IgG isotypes differ in complement activating function at the level of C4 as well as C1q.

1 reference

https://api.crossref.org/works/10.1111%2FBJH.12209

21 January 2018

The structural requirements for complement activation by IgG: does it hinge on the hinge?

1 reference

https://api.crossref.org/works/10.1111%2FBJH.12209

21 January 2018

Chimeric IgA antibodies against HLA class II effectively trigger lymphoma cell killing

1 reference

https://api.crossref.org/works/10.1111%2FBJH.12209

21 January 2018

Mechanisms of killing by anti-CD20 monoclonal antibodies.

1 reference

https://api.crossref.org/works/10.1111%2FBJH.12209

21 January 2018

Complement-induced cell death by rituximab depends on CD20 expression level and acts complementary to antibody-dependent cellular cytotoxicity

1 reference

https://api.crossref.org/works/10.1111%2FBJH.12209

21 January 2018

Competition for FcRn-mediated transport gives rise to short half-life of human IgG3 and offers therapeutic potential

1 reference

https://api.crossref.org/works/10.1111%2FBJH.12209

21 January 2018

Characterization of new human CD20 monoclonal antibodies with potent cytolytic activity against non-Hodgkin lymphomas

1 reference

https://api.crossref.org/works/10.1111%2FBJH.12209

21 January 2018

Human IgG subclass pattern of inducing complement-mediated cytolysis depends on antigen concentration and to a lesser extent on epitope patchiness, antibody affinity and complement concentration

1 reference

https://api.crossref.org/works/10.1111%2FBJH.12209

21 January 2018

Identifiers

10.1111/BJH.12209

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23294176

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23294176

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53126117&oldid=1561102068"